GALMARLEY LIMITED

1. Financial Health Score: B- (Incomplete Examination)

I am assigning a grade of B- with a significant caveat: this is a preliminary assessment based on a limited scope of examination. Because detailed financial metrics (revenue, profit/loss, current assets, and liabilities) were not provided in the patient's file, I cannot listen to the company's financial heartbeat in its entirety. However, based on the visible vital signs—specifically its two-decade longevity, strong corporate hygiene, and solid capital base—there are no immediate, outward symptoms of terminal distress. The grade reflects stability and compliance, tempered by the lack of detailed financial blood work.

2. Key Vital Signs

• Corporate Longevity (Incorporation Date: October 2003): This company is over 20 years old. In the fast-paced IT sector, surviving two decades is the equivalent of a patient running marathons into their senior years. It indicates resilience, adaptability, and a history of surviving economic illnesses (recessions, market shifts).
• Compliance Pulse (Filing Status: Not Overdue): The company’s confirmation statement and accounts are up to date, with the next accounts not due until mid-2027. This shows a healthy, regular corporate pulse. Companies showing symptoms of distress often let their regulatory filings slip, which is a classic fever marker for underlying administrative or financial chaos.
• Capital Bone Density (Share Capital: £359,717): The share capital represents the foundational "bone density" of the business. At nearly £360,000, this indicates that the owners have invested significant capital into the business over its lifetime, providing a sturdy skeletal structure to support operations.
• Organ Structure (Group Category & Officers): The company operates as a "Group," meaning it has subsidiary entities under its wing, and is managed by four directors and a secretary. This is a complex corporate anatomy. Furthermore, Mr. Paul Gerard Tustain owns between 25% and 50% of the voting rights, providing clear, concentrated leadership.

3. Diagnosis

Diagnosis: Stable but requiring full diagnostic imaging.

Based on the outward symptoms, Galmarley Limited is a mature, compliant, and structurally sound entity. Operating in SIC code 62090 (Other information technology service activities), the company exists in a sector that demands constant innovation. Its 20-year survival strongly suggests it has maintained a healthy cash flow and adapted to market treatments (technological shifts).

However, because the filed accounts data (current assets, liabilities, P&L reserves) is missing from this specific chart, we are essentially examining the patient with a stethoscope through a heavy winter coat. We can see the patient is breathing and walking, but we cannot diagnose the health of their working capital (current assets minus current liabilities) or check for arterial blockages (excessive short-term debt). The Group structure also means that the parent company's health might be artificially inflated or deflated by the performance of its subsidiaries, requiring a consolidated view to spot localized infections.

4. Recommendations

To move from a preliminary screening to a clean bill of health, the following actions are recommended:

• Conduct a Full Blood Panel (Review Filed Accounts): Request the latest fully filed accounts at Companies House. You must check the "cholesterol" levels—specifically the ratio of current assets to current liabilities. A ratio below 1:1 is a major symptom of liquidity distress.
• Monitor the Group's Contagion Risk: Because this is a Group entity, assess the health of the subsidiaries. A sick subsidiary can easily infect the parent company through bad debts or cash drain.
• Evaluate Cash Flow Respiration: In the IT services sector, cash flow is oxygen. Ensure that the P&L reserves are positive and that the company isn't surviving purely on life support (external debt or director loans).
• Succession Planning: With a key Person with Significant Control (Mr. Tustain) holding 25-50% of shares, ensure there are robust succession plans. A sudden departure could cause a corporate heart attack, disrupting operations and shareholding stability.